11:41 AM EST - Immunovaccine Inc. : Announced that new pre-clinical data on DepoVax™-based cancer vaccines will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2017, which will be held in Washington, D.C., from April 1-5. Immunovaccine Inc.
shares T.IMV are trading down $0.02 at $1.20.